PTSD :: Virtual 9/11 Brings Ground Zero Survivors Real Healing
Psychologists estimate that hundreds, even thousands, of people directly affected by the events of Sept. 11, 2001, are still crippled by post-traumatic stress disorder.
Therapy
Gene therapy for hereditary lung disease advances
A clinical trial to evaluate the safety of using a so-called gene vector to deliver a corrective gene to 12 patients with a common hereditary disorder that causes lung and liver disease is completed at the University of Florida. The gene therapy has caused no harmful effects in patients and hints at being effective.
COPD :: Home Oxygen Therapy for COPD – Clinical Trial
The National Heart, Lung, and Blood Institute (NHLBI), one of the National Institutes of Health (NIH), and the Centers for Medicare & Medicaid Services (CMS) is launching the largest randomized clinical trial of the effectiveness and safety of long-term, home oxygen therapy for COPD (chronic obstructive pulmonary disease). The six-year, $28 million project will study patients with moderate disease.
Heart Disease :: Researchers find insect protein effective for treating heart enlargement, arrythmias
Compounds known to play an important role in how insects develop from larvae to adults have been shown in a mouse model for congestive heart failure to be effective in preventing and reducing cardiac cell overgrowth and irregular heart rhythms, according to UC Davis research published in the early online edition of the Proceedings of the National Academy of Sciences.
Heart Disease :: Researchers Find Enzyme Inhibitor that Prevents, Reduces Heart Enlargement, Arrythmias
An enzyme inhibitor that regulates insect larvae development reduces heart enlargement and irregular heart rhythms in a mouse model, a 16-member University of California, Davis research team has discovered. The work, published in the current edition of Proceedings of the National Academy of Sciences, could lead to important new medications to treat human heart patients.
HIV :: 24-week results from Aptivus, tipranavir
Data from two 24-week analyses of the RESIST-1 and RESIST-2 studies, which evaluated Aptivus? (tipranavir) in treatment-experienced HIV-1 infected patients, were published in the 15 November issue of Clinical Infectious Diseases. Data demonstrate that at 24-weeks Aptivus, used with ritonavir (Aptivus/r) as part of combination antiretroviral therapy, achieved superior antiviral and immunological activity in treatment-experienced patients with multidrug-resistant HIV-1 infection.
New study finds no link between Kawasaki disease and newly discovered coronavirus
A newly described virus is not a cause of Kawasaki disease, according to an article by a group of researchers in Denver, Colorado. Their article appears in the December 15 issue of the Journal of Infectious Diseases, now available online.
Stroke :: Survivors of childhood leukemia, brain tumors more at risk for strokes later in life
Children who are successfully treated for brain tumors or leukemia are more likely to have strokes later in life, according to new research from UT Southwestern Medical Center.
Metabolic Syndrome :: Metabolic Syndrome Predicts Progressive Kidney Disease in African-Americans
For African-Americans with high blood pressure, the combination of risk factors known as metabolic syndrome brings an increased risk of worsening kidney disease, reports a paper being presented at the American Society of Nephrology’s 39th Annual Meeting and Scientific Exposition in San Diego.
Immunity :: Beta Agonists May Alter the Immune System and Worsen Asthma, Other Inflammatory Diseases
New research at Wake Forest University School of Medicine suggests that certain inhaled asthma medications ? as well as similar chemicals our bodies produce during times of high stress ? may worsen diseases such as asthma, heart failure and lupus that involve inflammation.